These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3624100)

  • 41. Disqualification of a clinical investigator--FDA. Final rule.
    Fed Regist; 1997 Sep; 62(172):46875-6. PubMed ID: 10173286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. U.S. Food and Drug Administration inspections of clinical investigators: overview of results from 1977 to 2009.
    Morgan-Linnell SK; Stewart DJ; Kurzrock R
    Clin Cancer Res; 2014 Jul; 20(13):3364-70. PubMed ID: 24737548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Causality Assessment in Premarketing Drug Clinical Trials: Regulatory Evolution in the USA and Ongoing Concerns.
    Goldman SA
    Drug Saf; 2016 Oct; 39(10):895-901. PubMed ID: 27473417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study of practical parameters and their relative importance as perceived by various stakeholders in clinical trials.
    Pant R; Joshi Y
    J Young Pharm; 2011 Jan; 3(1):60-4. PubMed ID: 21607056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug regulation and policy formulation.
    Nightingale SL
    Milbank Mem Fund Q Health Soc; 1981; 59(3):412-44. PubMed ID: 7024847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of efficacy of heartworm preventive products at the FDA.
    Hampshire VA
    Vet Parasitol; 2005 Oct; 133(2-3):191-5. PubMed ID: 16099105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FDA notifications. FDA may expand clinical investigator restrictions.
    AIDS Alert; 2011 Jun; 26(6):71. PubMed ID: 27024081
    [No Abstract]   [Full Text] [Related]  

  • 49. Challenges for academic investigator-initiated pediatric trials for rare diseases.
    Ahmed R; Duerr U; Gavenis K; Hilgers R; Gross O
    Clin Ther; 2014 Feb; 36(2):184-90. PubMed ID: 24529291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New food safety initiatives in the Food and Drug Administration.
    Fitzpatrick SC
    J Anim Sci; 1990 Mar; 68(3):870-3. PubMed ID: 2180882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Organization, administration, and performance of clinical studies].
    Bachner M; Steininger T; Gneist M
    Onkologie; 2008; 31 Suppl 2():3-6. PubMed ID: 18487861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research activities in the Bureau of Veterinary Medicine.
    Norcross MA
    J Am Vet Med Assoc; 1982 Jan; 180(1):32. PubMed ID: 7199037
    [No Abstract]   [Full Text] [Related]  

  • 53. A study of warning letters issued to clinical investigators by the United States Food and Drug Administration.
    Bramstedt KA
    Clin Invest Med; 2004 Jun; 27(3):129-34. PubMed ID: 15305804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory Considerations for the Approval of Drugs Against Histomoniasis (Blackhead Disease) in Turkeys, Chickens, and Game Birds in the United States.
    Regmi PR; Shaw AL; Hungerford LL; Messenheimer JR; Zhou T; Pillai P; Omer A; Gilbert JM
    Avian Dis; 2016 Dec; 60(4):725-730. PubMed ID: 27902913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. So You Want to Be a Principal Investigator.
    Saleh M; Naik G
    J Oncol Pract; 2018 Jun; 14(6):e384-e392. PubMed ID: 29750578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current good manufacturing practice regulation and investigational new drugs. Direct final rule.
    Food and Drug Administration. HHS
    Fed Regist; 2006 Jan; 71(10):2458-62. PubMed ID: 16479693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development, manufacture, and distribution of animal drugs.
    Miller CC
    J Dairy Sci; 1978 May; 61(5):665-8. PubMed ID: 670483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Internal challenge to clinical trial project management: strategies for managing investigator compliance.
    Cao H; Shang H; Mu W; Zhai J; Hou Y; Wang H
    J Evid Based Med; 2013 Aug; 6(3):157-66. PubMed ID: 24325372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Institution/investigator-initiated clinical trials in Canada.
    Sedgeworth J; Derewlany L
    Can J Clin Pharmacol; 2006; 13(2):e236-9. PubMed ID: 16873897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The investigative process for new drugs.
    Nicklas RA
    Ann Allergy; 1989 Dec; 63(6 Pt 2):598-600. PubMed ID: 2688499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.